The Israeli company has developed a platform in collaboration with leading Weizmann Institute researchers that enables molecular-level accurate control in the design of scent
Read more here.
The Israeli company has developed a platform in collaboration with leading Weizmann Institute researchers that enables molecular-level accurate control in the design of scent
Read more here.
![[OncoHost in PR Newswire] OncoHost Collaborates with BGN Technologies to Predict Cancer Patient Response to Anti-PD-1 Treatment with IcAR Biosensing Tech](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
